Peripheral Neuropathy Trial, Recruiting NCT07482137 Sponsor: Zhongda Hospital Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07482137
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a diabetic foot ulcer
  • People whose condition has been assessed under Traditional Chinese Medicine principles and classified as a "blood stasis obstructing the collateral pattern" (confirm with trial site)
  • People whose foot ulcer is rated at Wagner Grade 1, 2, or 3, and whose ulcer measures between 2 cm² and 30 cm² in size
  • People aged between 18 and 75 years, male or female
  • People who are willing to take part, are able to follow the study requirements, and have signed a consent form agreeing to participate

Who may not be able to join:

  • People who have serious disease affecting the brain, liver, heart, lungs, or kidneys
  • People who are pregnant or planning to become pregnant during the study period
  • People whose blood sugar control measure (called HbA1c) is 9% or higher — this is a test that shows average blood sugar levels over several months
  • People who have a psychiatric (mental health) disorder
  • People who have a genetic condition, an infectious disease, a cancer, or another serious illness associated with a short life expectancy
  • People who are currently taking part in another clinical trial, or who have taken part in one within the four weeks before joining this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13912992162

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhongda Hospital
Registry
ClinicalTrials.gov
Start date
15 July 2025
Est. completion
30 September 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Wagner Grade and Ankle-Brachial Index (ABI) Measurement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov